Preoperative immunotherapy combined with chemotherapy for triple-negative breast cancer: Perspective on the KEYNOTE-522 study Editorial

  

Authors:	Downs-Canner, S.; Mittendorf, E. A.
Title:	Preoperative immunotherapy combined with chemotherapy for triple-negative breast cancer: Perspective on the KEYNOTE-522 study
Keywords:	cancer chemotherapy; event free survival; doxorubicin; note; paclitaxel; neoadjuvant therapy; antineoplastic agent; carboplatin; cancer immunotherapy; antineoplastic combined chemotherapy protocols; cyclophosphamide; docetaxel; immunotherapy; epirubicin; preoperative treatment; randomized controlled trial (topic); phase 2 clinical trial (topic); triple negative breast cancer; preoperative chemotherapy; humans; human; pembrolizumab; atezolizumab; triple negative breast neoplasms; antineoplastic monoclonal antibody
Journal Title:	Annals of Surgical Oncology
Volume:	30
Issue:	6
ISSN:	1068-9265
Publisher:	Springer
Date Published:	2023-06-01
Start Page:	3166
End Page:	3169
Language:	English
DOI:	10.1245/s10434-023-13267-z
PUBMED:	36897418
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149923429&doi=10.1245%2fs10434-023-13267-z&partnerID=40&md5=53be418d26642d648f3f6c5a7bfa796f
Notes:	Note -- Erratum issued, see DOI: 10.1245/s10434-023-13448-w -- Export Date: 31 May 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/206612